Tanya Dorff1, James Shen2, Nora Ruel3, Rick Kittles3, Yung Lyou2, Savita Dandapani4, Jeff Wong4, Huiqing Wu5, Sumanta Pal2, Clayton Lau6, Bertram Yuh6. 1. City of Hope Comprehensive Cancer Center, Department of medical oncology and developmental therapeutics, Duarte, CA United States. Electronic address: tdorff@coh.org. 2. City of Hope Comprehensive Cancer Center, Department of medical oncology and developmental therapeutics, Duarte, CA United States. 3. City of Hope Comprehensive Cancer Center, Department of Compuational and Quantitative Medicine, Duarte, CA United States. 4. City of Hope Comprehensive Cancer Center, Department of Radiation Oncology, Duarte, CA United States. 5. City of Hope Comprehensive Cancer Center, Department of Pathology, Duarte, CA United States. 6. City of Hope Comprehensive Cancer Center, Department of Surgery, Duarte, CA United States.
Abstract
BACKGROUND: Prostate cancer is the most commonly diagnosed cancer in American men, with striking differences between ethnic groups. Given the potential for lifestyle or genetic variations between subsets of Asian-American men to impact prostate cancer behavior, we sought to define the outcomes after radical prostatectomy among various Asian groups treated at an NCI-designated comprehensive cancer center. METHODS: The City of Hope IRB-approved prostatectomy database was searched from 2003 to 2015 to identify Asian-American men. Clinical and pathologic features were collected and analyzed for association with biochemical recurrence-free survival and overall survival (OS). Categorical data were evaluated using χ2and Fisher's exact tests. Survival curves were compared between groups using log-rank testing. RESULTS: Three hundred and eighty-three Asian-American men were included in the dataset. While Asian men as a group had lower BMI than African-American and white men in the database, there was a wide range between ethnic sub-groups. Chinese men more commonly presented with D'Amico low risk disease features (P= .04) compared to other Asian men. Pacific Islander men had the lowest rate of ≥T3 stage and the highest biochemical recurrence-free survival. OS for Chinese men was better than for all Asian patients combined (P= .046). After controlling for D'Amico risk and in multivariate analysis, Chinese men still had improved OS than other Asian men after prostatectomy (P= .03). CONCLUSIONS: Asian-American men have differing prostate cancer characteristics. Future efforts to delineate and impact upon prostate cancer outcomes should categorize Asian men by subgroup in order to better elucidate biology, lifestyle factors and/or treatment preferences that may contribute to observed differences.
BACKGROUND: Prostate cancer is the most commonly diagnosed cancer in American men, with striking differences between ethnic groups. Given the potential for lifestyle or genetic variations between subsets of Asian-American men to impact prostate cancer behavior, we sought to define the outcomes after radical prostatectomy among various Asian groups treated at an NCI-designated comprehensive cancer center. METHODS: The City of Hope IRB-approved prostatectomy database was searched from 2003 to 2015 to identify Asian-American men. Clinical and pathologic features were collected and analyzed for association with biochemical recurrence-free survival and overall survival (OS). Categorical data were evaluated using χ2and Fisher's exact tests. Survival curves were compared between groups using log-rank testing. RESULTS: Three hundred and eighty-three Asian-American men were included in the dataset. While Asian men as a group had lower BMI than African-American and white men in the database, there was a wide range between ethnic sub-groups. Chinese men more commonly presented with D'Amico low risk disease features (P= .04) compared to other Asian men. Pacific Islander men had the lowest rate of ≥T3 stage and the highest biochemical recurrence-free survival. OS for Chinese men was better than for all Asian patients combined (P= .046). After controlling for D'Amico risk and in multivariate analysis, Chinese men still had improved OS than other Asian men after prostatectomy (P= .03). CONCLUSIONS: Asian-American men have differing prostate cancer characteristics. Future efforts to delineate and impact upon prostate cancer outcomes should categorize Asian men by subgroup in order to better elucidate biology, lifestyle factors and/or treatment preferences that may contribute to observed differences.
Authors: Cristina Magi-Galluzzi; Toyonori Tsusuki; Paul Elson; Kelly Simmerman; Chris LaFargue; Raquel Esgueva; Eric Klein; Mark A Rubin; Ming Zhou Journal: Prostate Date: 2010-09-28 Impact factor: 4.104
Authors: Siamak Daneshmand; Tanya B Dorff; Marcus L Quek; Jie Cai; Malcolm C Pike; Peter W Nichols; Jacek Pinski Journal: Urology Date: 2005-05 Impact factor: 2.649
Authors: R A Kittles; D Young; S Weinrich; J Hudson; G Argyropoulos; F Ukoli; L Adams-Campbell; G M Dunston Journal: Hum Genet Date: 2001-09 Impact factor: 4.132
Authors: Daphne Y Lichtensztajn; Scarlett Lin Gomez; Weiva Sieh; Benjamin I Chung; Iona Cheng; James D Brooks Journal: J Urol Date: 2013-10-25 Impact factor: 7.450
Authors: A S Whittemore; A H Wu; L N Kolonel; E M John; R P Gallagher; G R Howe; D W West; C Z Teh; T Stamey Journal: Am J Epidemiol Date: 1995-04-15 Impact factor: 4.897
Authors: Low Wei Xiang Alvin; Sim Hong Gee; Huang Hong Hong; Cheng Wai Sam Christopher; Ho Sien Sun Henry; Lau Kam On Weber; Tan Puay Hoon; Lee Lui Shiong Journal: J Robot Surg Date: 2015-07-07